Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to Exacerbated Citrobacter rodentium -Induced Colitis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Antibiotics are often used in the clinic to treat bacterial infections, but the effects of these drugs on microbiota composition and on intestinal immunity are poorly understood. Citrobacter rodentium was used as a model enteric pathogen to investigate the effect of microbial perturbation on intestinal barriers and susceptibility to colitis. Streptomycin and metronidazole were used to induce alterations in the composition of the microbiota prior to infection with C. rodentium. Metronidazole pretreatment increased susceptibility to C. rodentium-induced colitis over that of untreated and streptomycin-pretreated mice, 6 days postinfection. Both antibiotic treatments altered microbial composition, without affecting total numbers, but metronidazole treatment resulted in a more dramatic change, including a reduced population of Porphyromonadaceae and increased numbers of lactobacilli. Disruption of the microbiota with metronidazole, but not streptomycin treatment, resulted in an increased inflammatory tone of the intestine characterized by increased bacterial stimulation of the epithelium, altered goblet cell function, and thinning of the inner mucus layer, suggesting a weakened mucosal barrier. This reduction in mucus thickness correlates with increased attachment of C. rodentium to the intestinal epithelium, contributing to the exacerbated severity of C. rodentium-induced colitis in metronidazole-pretreated mice. These results suggest that antibiotic perturbation of the microbiota can disrupt intestinal homeostasis and the integrity of intestinal defenses, which protect against invading pathogens and intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mucus production is another mediator of indirect colonization resistance.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [49]
In the citing paper
“Treatment with metronidazole, which selectively depletes anaerobes, but not streptomycin, reduced the thickness of the inner mucus layer in the large intestine (LI) – a process that depends on NLRP6 – and increased susceptibility to oral C. rodentium infection in mice [49, 50].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 2×
“The intestinal microbiota can be thought of as an organ system, essential for nutrient acquisition, metabolism of indigestible compounds, defense against colonization by pathogens, and the development of intestinal architecture and the immune system (40, 43).”
BackgroundFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 1×
“Further, there are significant differences in microbiota compositions of inflammatory bowel disease (IBD) patients and healthy individuals, further implicating microbial factors in the initiation and perpetuation of colitis (17, 19, 32, 46).”
BackgroundAmann, R. I., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,021 · cited 1×
“Eubacteria 16S rRNA (total bacteria) (1) UniF340 ACTCCTACGGGAGGCAGCAGT 63 UniR514 ATTACCGCGGCTGCTGGC”
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409 · cited 1×
“Degradation of these mucin peptides and O-linked glycans serves as an energy source for the intestinal microbiota and consequently results in the production of short-chain fatty acids such as acetate and butyrate (15, 25), which are able to diffuse through the inner mucus layer and stimulate the underlying epithelial…”
BackgroundThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200 · cited 6×
“The mucus layer in the large intestine consists of two stratified layers mainly composed of the secreted mucin Muc2 (26).”
BackgroundResultInfluentialMucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807 · cited 1×
“The inner dense mucus layer functions as a barrier, which serves to minimize microbial translocation and prevent excessive immune activation (22).”
BackgroundIvanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770 · cited 1×
“While the microbiota likely represent a physical barrier that prevents pathogens from interacting with and penetrating the intestinal mucosa (50), other studies suggest a much higher degree of complexity that involves a direct role for the microbiota in dictating the immunological tone of the intestine (12, 24, 44).”
BackgroundSelf-citationVan der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684 · cited 5×
“These proteins have defined roles in intestinal homeostasis: Muc2 is the main component of the intestinal mucin layer (26); intestinal trefoil factor (TFF3) synergizes with Muc2, enhancing the protective properties of the mucus layer (55); and Relm has an important role in innate immunity and host defense (3, 39).”
BackgroundResultInfluentialJohansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432 · cited 2×
“In light of previous studies (9, 12, 28, 59), this is interpreted as increased stimulation of the colonic epithelium by the microbiota as a result of a depleted inner mucus layer.”
BackgroundMucins in the mucosal barrier to infection
Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V, & McGuckin, M. A. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.5 · Cited by 1,234 · cited 1×
“The intestinal mucus layer plays a key role in the maintenance of intestinal homeostasis: it protects the epithelium from dehydration, physical abrasion, and invading microorganisms (33).”
BackgroundThe adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
Atuma, C., Strugala, V., Allen, A., & Holm, L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.5.g922 · Cited by 1,078 · cited 1×
“the intestinal tract and is thickest in the most distal portion (4),”
BackgroundFranks, A. H., Harmsen, H. J. M., Raangs, G. C., Jansen, G. J., Schut, F., & Welling, G. W. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.9.3336-3345.1998 · Cited by 1,056
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052 · cited 2×
“Metronidazole is used extensively in the treatment of IBD, with variable efficacy (20, 45).”
BackgroundRinttila, T., Kassinen, A., Malinen, E., Krogius, L., & Palva, A. (2004) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02409.x · Cited by 1,017 · cited 1×
“Lactobacillus 16S rRNA (42) LabF362 AGCAGTAGGGAATCTTCCA 56 LabR677 CACCGCTACACATGGAG”
BackgroundLangendijk, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M. H., & Welling, G. W. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.8.3069-3075.1995 · Cited by 975 · cited 1×
“Bifidobacterium 16S rRNA (30) Bif164F GGGTGGTAATGCCGGATG 62 Bif662R CCACCGTTACACCGGGAA”
BackgroundCommunicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System
Garrett, W. S., Lord, G. M., Punit, S., Lugo-Villarino, G., Mazmanian, S. K., Ito, S., Glickman, J. N., & Glimcher, L. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.017 · Cited by 918 · cited 1×
“Further, there are significant differences in microbiota compositions of inflammatory bowel disease (IBD) patients and healthy individuals, further implicating microbial factors in the initiation and perpetuation of colitis (17, 19, 32, 46).”
BackgroundMack, D. R., Michail, S., Wei, S., McDougall, L., & Hollingsworth, M. A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g941 · Cited by 829 · cited 1×
“Studies using mucinknockout mice, germfree (GF) mice, and probiotics suggest that the intestinal mucus layer is a major mediator of microbeIEC interactions and that mucus integrity is largely affected by the microbiota (26, 34, 55).”
BackgroundVancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2008) · Nature · doi:10.1038/nature07250 · Cited by 631
Bacterial Adhesins in Host-Microbe Interactions
Kline, K. A., Fälker, S., Dahlberg, S., Normark, S., & Henriques-Normark, B. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.011 · Cited by 630 · cited 1×
“The metronidazole-induced reduction in the Bacteroidales order within the Bacteroidetes phylum is particularly interesting; members of the Bacteroidetes phylum, specifically Bacteroides thetaiotaomicron, have been shown to be important colonizers and grazers of the outer mucus layer in humans (29, 37, 49).”
BackgroundBergstrom, K. S. B., Kissoon-Singh, V., Gibson, D. L., Ma, C., Montero, M., Sham, H. P., Ryz, N., Huang, T., Velcich, A., Finlay, B. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000902 · Cited by 625 · cited 1×
“tium-induced colitis (6, 54, 55) due to a closer interaction of”
BackgroundSelf-citationBurger-van Paassen, N., Vincent, A., Puiman, P. J., van der Sluis, M., Bouma, J., Boehm, G., van Goudoever, J. B., van Seuningen, I., & Renes, I. B. (2009) · Biochemical Journal · doi:10.1042/bj20082222 · Cited by 611
The role of microbiota in infectious disease
Stecher, B., & Hardt, W.-D. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 535 · cited 1×
“penetrating the intestinal mucosa (50), other studies suggest a”
BackgroundDouble blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L., Singleton, J., Sessions, J., Hanauer, S., Krawitt, E., Rankin, G., Summers, R., Mekhjian, H., Greenberger, N., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 528 · cited 1×
“In Crohn’s disease, the use of metronidazole is still highly controversial, as it shows variable efficacy (2, 8, 51, 52).”
BackgroundSekirov, I., Tam, N. M., Jogova, M., Robertson, M. L., Li, Y., Lupp, C., & Finlay, B. B. (2008) · Infection and Immunity · doi:10.1128/iai.00319-08 · Cited by 490 · cited 2×
“A well-known case of this is antibiotic treatment, and previous studies have shown that antibiotic treatment can predispose the host to enteric infections (48).”
BackgroundCitrobacter rodentium of mice and man
Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G., & Wiles, S. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00625.x · Cited by 481 · cited 1×
“We hypothesized that an alteration in intestinal microbial composition by antibiotic treatments would alter susceptibility to the natural mouse pathogen Citrobacter rodentium, which results in intestinal inflammation with features similar to those of ulcerative colitis (38).”
BackgroundSalzman, N. H., Underwood, M. A., & Bevins, C. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.04.002 · Cited by 414 · cited 1×
“While the microbiota likely represent a physical barrier that prevents pathogens from interacting with and penetrating the intestinal mucosa (50), other studies suggest a much higher degree of complexity that involves a direct role for the microbiota in dictating the immunological tone of the intestine (12, 24, 44).”
BackgroundSonnenburg, J. L., Angenent, L. T., & Gordon, J. I. (2004) · Nature Immunology · doi:10.1038/ni1079 · Cited by 404 · cited 1×
“The metronidazole-induced reduction in the Bacteroidales order within the Bacteroidetes phylum is particularly interesting; members of the Bacteroidetes phylum, specifically Bacteroides thetaiotaomicron, have been shown to be important colonizers and grazers of the outer mucus layer in humans (29, 37, 49).”
BackgroundRole of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens
Dharmani, P., Srivastava, V., Kissoon-Singh, V., & Chadee, K. (2009) · Journal of Innate Immunity · doi:10.1159/000163037 · Cited by 328 · cited 1×
“Degradation of these mucin peptides and O-linked glycans serves as an energy source for the intestinal microbiota and consequently results in the production of short-chain fatty acids such as acetate and butyrate (15, 25), which are able to diffuse through the inner mucus layer and stimulate the underlying epithelial…”
BackgroundRELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract
Artis, D., Wang, M. L., Keilbaugh, S. A., He, W., Brenes, M., Swain, G. P., Knight, P. A., Donaldson, D. D., Lazar, M. A., Miller, H. R. P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404034101 · Cited by 326
Mucin gene structure and expression: protection vs. adhesion
Van Klinken, B. J., Dekker, J., Buller, H. A., & Einerhand, A. W. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.5.g613 · Cited by 319 · cited 1×
“pounds, including mucins, trefoil factors, and other antimicrobials (53, 56).”
BackgroundCommensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine
Zaph, C., Du, Y., Saenz, S. A., Nair, M. G., Perrigoue, J. G., Taylor, B. C., Troy, A. E., Kobuley, D. E., Kastelein, R. A., Cua, D. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080720 · Cited by 293 · cited 2×
“Additionally, recognition of commensals by IECs has been shown to be important in regulating the inflammatory state of the intestine, through regulation of the interleukin-25 (IL-25)–IL-23–IL-17 axis and Th17 cells (59).”
BackgroundChapman, R. W., Selby, W. S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.10.1210 · Cited by 284 · cited 1×
“In ulcerative colitis, metronidazole has been found to be ineffective in double-blind, placebo-controlled trials, compared to standard steroid treatment (13, 36).”
BackgroundThia, K. T., Mahadevan, U., Feagan, B. G., Wong, C., Cockeram, A., Bitton, A., Bernstein, C. N., & Sandborn, W. J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20608 · Cited by 278
Lepage, P., Seksik, P., Sutren, M., de la Cochetière, M.-F., Jian, R., Marteau, P., & Doré, J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000159662.62651.06 · Cited by 270 · cited 1×
“Further, there are significant differences in microbiota compositions of inflammatory bowel disease (IBD) patients and healthy individuals, further implicating microbial factors in the initiation and perpetuation of colitis (17, 19, 32, 46).”
BackgroundDo symbiotic bacteria subvert host immunity?
Hooper, L. V. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2114 · Cited by 255 · cited 5×
“Metronidazole pretreatment increases the rate of C. rodentium attachment to IECs.”
BackgroundInfluentialCulture‐independent analysis of the gut microbiota in colorectal cancer and polyposis
Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'Sullivan, G. C., O'Riordan, M., Holmes, E., Wang, Y., & Marchesi, J. R. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01503.x · Cited by 245 · cited 1×
“Further, there are significant differences in microbiota compositions of inflammatory bowel disease (IBD) patients and healthy individuals, further implicating microbial factors in the initiation and perpetuation of colitis (17, 19, 32, 46).”
BackgroundJohansson, M. E. V., Thomsson, K. A., & Hansson, G. C. (2009) · Journal of Proteome Research · doi:10.1021/pr9002504 · Cited by 237 · cited 1×
“tinal lumen localizes to the mucin layer (27), attesting to its”
BackgroundTrefoil peptides: from structure to function
Thim, L. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050108 · Cited by 215 · cited 1×
“pounds, including mucins, trefoil factors, and other antimicrobials (53, 56).”
BackgroundDeng, W., Vallance, B. A., Li, Y., Puente, J. L., & Finlay, B. B. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03429.x · Cited by 195 · cited 1×
“using antibodies against Tir (antibody production described previously [14]) or”
MethodMartens, E. C., Roth, R., Heuser, J. E., & Gordon, J. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008094 · Cited by 183 · cited 1×
“The metronidazole-induced reduction in the Bacteroidales order within the Bacteroidetes phylum is particularly interesting; members of the Bacteroidetes phylum, specifically Bacteroides thetaiotaomicron, have been shown to be important colonizers and grazers of the outer mucus layer in humans (29, 37, 49).”
BackgroundMantzaris, G. J., Hatzis, A., Kontogiannis, P., & Triadaphyllou, G. (1994) · PubMed · Cited by 171
Doré, J., Sghir, A., Hannequart-Gramet, G., Corthier, G., & Pochart, P. (1998) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(98)80009-x · Cited by 171 · cited 1×
“Bacteroidales 16S rRNA (16) BactF285 GGTTCTGAGAGGAAGGTCCC 61 UniR338 GCTGCCTCCCGTAGGAGT”
BackgroundCommensals, Bacterial Pathogens and Intestinal Inflammation: An Intriguing Ménage à Trois
Pédron, T., & Sansonetti, P. J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.010 · Cited by 169 · cited 1×
“The intestinal microbiota can be thought of as an organ system, essential for nutrient acquisition, metabolism of indigestible compounds, defense against colonization by pathogens, and the development of intestinal architecture and the immune system (40, 43).”
BackgroundWILLING, B., VÖRÖS, A., ROOS, S., JONES, C., JANSSON, A., & LINDBERG, J. E. (2009) · Equine Veterinary Journal · doi:10.2746/042516409x447806 · Cited by 167
Metronidazole in Crohn's Disease: A Double Blind Cross-over Clinical Trial
Blichfeldt, P., Blomhoff, J. P., Myhre, E., & Gjone, E. (1978) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527809179816 · Cited by 148 · cited 1×
“In Crohn’s disease, the use of metronidazole is still highly controversial, as it shows variable efficacy (2, 8, 51, 52).”
BackgroundBergstrom, K. S. B., Guttman, J. A., Rumi, M., Ma, C., Bouzari, S., Khan, M. A., Gibson, D. L., Vogl, A. W., & Vallance, B. A. (2008) · Infection and Immunity · doi:10.1128/iai.00093-07 · Cited by 145 · cited 1×
“rodentium and other attaching and effacing pathogens (5).”
BackgroundAntibiotics and probiotics in treatment of inflammatory bowel disease
Gionchetti, P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i21.3306 · Cited by 113 · cited 2×
“Metronidazole is used extensively in the treatment of IBD, with variable efficacy (20, 45).”
BackgroundAmbrose, N. S., Allan, R. N., Keighley, M. R. B., Burdon, D. W., Youngs, D., Barnes, P., & Lennard-Jones, J. E. (1985) · Diseases of the Colon & Rectum · doi:10.1007/bf02552649 · Cited by 107
Nair, M. G., Guild, K. J., Du, Y., Zaph, C., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A., Stevens, S., Karow, M., & Artis, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4709 · Cited by 101
Yang, K., Popova, N. V., Yang, W. C., Lozonschi, I., Tadesse, S., Kent, S., Bancroft, L., Matise, I., Cormier, R. T., Scherer, S. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0598 · Cited by 96 · cited 1×
“Our findings are consistent with similar experiments performed in Muc2-knockout mice, showing that these mice exhibit enhanced mucosal permeability and subclinical levels of chronic inflammation due to increased stimulation of epithelial cells by intestinal bacteria (55, 58).”
ResultKeilbaugh, S. A., Shin, M. E., Banchereau, R. F., McVay, L. D., Boyko, N., Artis, D., Cebra, J. J., & Wu, G. D. (2005) · Gut · doi:10.1136/gut.2004.056028 · Cited by 85
Hoebler, C., Gaudier, E. A., de Coppet, P., Rival, M., & Cherbut, C. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3142-y · Cited by 81 · cited 9×
“TFF3-R GCCACGGTTGTTACACTGCTC”
InfluentialThe Attachment Site of Streptomycin to the 30S Ribosomal Subunit
Biswas, D. K., & Gorini, L. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2141 · Cited by 60 · cited 1×
“Streptomycin is a broad-spectrum antibiotic that kills sensitive microbes by binding to the 30S subunit of the bacterial ribosome and inhibiting protein synthesis (7).”
BackgroundPélissier, M.-A., Vasquez, N., Balamurugan, R., Pereira, E., Dossou-Yovo, F., Suau, A., Pochart, P., & Magne, F. (2010) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2010.00916.x · Cited by 55 · cited 3×
“Additionally, although this study suggests that metronidazole causes thickening of the mucus layer, it has also shown a closer association of microbes with the intestinal epithelium (41).”
BackgroundResultInfluentialvan der Sluis, M., Bouma, J., Vincent, A., Velcich, A., Carraway, K. L., Büller, H. A., Einerhand, A. W. C., van Goudoever, J. B., Van Seuningen, I., & Renes, I. B. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.28 · Cited by 44 · cited 1×
“tium-induced colitis (6, 54, 55) due to a closer interaction of”
BackgroundFate of Goblet Cells in Experimental Colitis
Makkink, M. K., Schwerbrock, N. M. J., Mähler, M., Boshuizen, J. A., Renes, I. B., Cornberg, M., Hedrich, H. J., Einerhand, A. W. C., Büller, H. A., Wagner, S., et al. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020147630032 · Cited by 31 · cited 1×
“These molecules provide defense against pathogens by preventing bacterial penetration of the intestinal epithelium, and they play a key role in the maintenance of healthy intestinal homeostasis (35).”
BackgroundMetronidazole (Flagyl): Degradation by the Intestinal Flora
Searle, A., & WILLSON, R. L. (1976) · Xenobiotica · doi:10.3109/00498257609151658 · Cited by 26 · cited 1×
“Metronidazole targets anaerobic bacteria and sensitive protozoa, as these organisms are capable of nitroreduction of metronidazole, converting it to its active form, leading to DNA damage (47).”
Background
Research works printed but not linked: 1
- Legendre, P., and L. Legendre. 1998. Numerical ecology, 2nd English ed., vol. 2. Elsevier, Amsterdam, Netherlands.
Cited by
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613
The Intestinal Microbiome in Early Life: Health and Disease
Arrieta, M.-C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M., & Finlay, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00427 · Cited by 1,024
Self-citation
Metadata
- Authors
- Wlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., Russell, S. L., Vallance, B. A., & Finlay, B. B.
- Affiliations
- University of British Columbia (CA)
- Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4
- Child and Family Research Institute (CA)
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 79
- Issue
- 4
- Pages
- 1536-1545
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC3067531
- OpenAlex
- W2128743925
- Cited by
- 382
- References
- 58
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 27 · 2023: 19 · 2022: 30 · 2021: 33 · 2020: 31 · 2019: 32 · 2018: 29 · 2017: 24 · 2016: 31 · 2015: 22 · 2014: 26 · 2013: 23 · 2012: 17
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- antibiotic therapy, metronidazole, streptomycin, Citrobacter rodentium, colitis, colonic mucus layer, gut microbiota, intestinal barrier, goblet cells, Porphyromonadaceae, Lactobacillus, intestinal inflammation, dysbiosis
- MeSH terms
- Animals, Anti-Bacterial Agents, Cell Separation, Colitis, Enterobacteriaceae Infections, Female, Flow Cytometry, Immunohistochemistry, Intestinal Mucosa, Metronidazole, Mice, Inbred C57BL, Streptomycin, Immunity, Mucosal, Reverse Transcriptase Polymerase Chain Reaction, Citrobacter rodentium, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.